authors
- Rabe, KF
- Castro, M
- Nair, Parameswaran Krishna
- Rice, MS
- Rowe, P
- Deniz, Y
- Staudinger, H
- Graham, NMH
- Amin, N
- Teper, A
Dupilumab reduces oral corticosteroid (OCS) use and severe exacerbations, and improves FEV1 in OCS-dependent, severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- August 1, 2019
has subject area
- 1107 Immunology (FoR)
- Allergy (Science Metrix)